• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床和分子水平系统性淀粉样变性研究的计算工具与方法

Computational Tools and Methods for the Study of Systemic Amyloidosis at the Clinical and Molecular Level.

作者信息

Di Silvestre Dario, Brambilla Francesca, Merlini Giampaolo, Mauri Pierluigi

机构信息

Institute for Biomedical Technologies - National Research Council (ITB-CNR), Segrate, Milan, Italy.

Amyloidosis Research and Treatment Centre, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy.

出版信息

Methods Mol Biol. 2025;2884:369-387. doi: 10.1007/978-1-0716-4298-6_22.

DOI:10.1007/978-1-0716-4298-6_22
PMID:39716014
Abstract

Amyloidosis diseases are characterized by protein misfolding, which forms insoluble beta-sheet fibrils progressively deposited in tissues. Deposition in the form of amyloid aggregates can occur in various organs, damaging their structure and function. The hallmark of amyloidosis is aberrant interactions leading to protein aggregation and proteotoxicity. Accordingly, amyloidosis-related samples represent a valuable source of information to generate new knowledge useful for diagnostic, prognostic, and therapeutic purposes. In this scenario, we outline the path to apply computational methods and strategies based on the combination of proteomics and systems biology approaches. In addition to algorithms useful for subtyping amyloid deposits or assessing proteome recovery after drug treatment, our chapter provides workflows based on protein-protein interaction and protein co-expression network models. In particular, the main steps to reconstruct and analyze them at both functional and topological levels are described. Our chapter aims to provide tools and instructions to identify and monitor prognostic, diagnostic, and therapeutic markers and to shed light on the processes, pathways, and functions affected by amyloidogenic proteins.

摘要

淀粉样变性疾病的特征是蛋白质错误折叠,形成不溶性β-折叠原纤维并逐渐沉积在组织中。淀粉样聚集体形式的沉积可发生在各种器官中,损害其结构和功能。淀粉样变性的标志是异常相互作用导致蛋白质聚集和蛋白毒性。因此,与淀粉样变性相关的样本是产生有助于诊断、预后和治疗目的新知识的宝贵信息来源。在这种情况下,我们概述了应用基于蛋白质组学和系统生物学方法相结合的计算方法和策略的途径。除了可用于淀粉样沉积物亚型分类或评估药物治疗后蛋白质组恢复情况的算法外,我们的章节还提供了基于蛋白质-蛋白质相互作用和蛋白质共表达网络模型的工作流程。特别是,描述了在功能和拓扑层面重建和分析它们的主要步骤。我们的章节旨在提供工具和指导,以识别和监测预后、诊断和治疗标志物,并阐明受淀粉样蛋白影响的过程、途径和功能。

相似文献

1
Computational Tools and Methods for the Study of Systemic Amyloidosis at the Clinical and Molecular Level.临床和分子水平系统性淀粉样变性研究的计算工具与方法
Methods Mol Biol. 2025;2884:369-387. doi: 10.1007/978-1-0716-4298-6_22.
2
Clinical Amyloid Typing by Proteomics: Performance Evaluation and Data Sharing Between Two Centres.基于蛋白质组学的临床淀粉样变分型:两个中心的性能评估和数据共享。
Molecules. 2021 Mar 29;26(7):1913. doi: 10.3390/molecules26071913.
3
Clinical proteomics for diagnosis and typing of systemic amyloidoses.用于系统性淀粉样变性病诊断和分型的临床蛋白质组学。
Proteomics Clin Appl. 2013 Jan;7(1-2):136-43. doi: 10.1002/prca.201200097.
4
Proteomics in molecular diagnosis: typing of amyloidosis.分子诊断中的蛋白质组学:淀粉样变性的分型
J Biomed Biotechnol. 2011;2011:754109. doi: 10.1155/2011/754109. Epub 2011 Oct 29.
5
Confirming the Diagnosis of Amyloidosis.明确淀粉样变性的诊断。
Acta Haematol. 2020;143(4):312-321. doi: 10.1159/000508022. Epub 2020 Jun 16.
6
Amyloidosis: Insights from Proteomics.淀粉样变:蛋白质组学的新视角。
Annu Rev Pathol. 2017 Jan 24;12:277-304. doi: 10.1146/annurev-pathol-052016-100200. Epub 2016 Dec 5.
7
Proteomic typing of amyloid deposits in systemic amyloidoses.系统性淀粉样变性中淀粉样沉积物的蛋白质组学分型。
Amyloid. 2011 Dec;18(4):177-82. doi: 10.3109/13506129.2011.630762.
8
Diagnostic amyloid proteomics: experience of the UK National Amyloidosis Centre.诊断淀粉样蛋白组学:英国国家淀粉样变性中心的经验。
Clin Chem Lab Med. 2020 Jun 25;58(6):948-957. doi: 10.1515/cclm-2019-1007.
9
Systemic Amyloidosis: a Contemporary Overview.系统性淀粉样变:当代概述。
Clin Rev Allergy Immunol. 2020 Dec;59(3):304-322. doi: 10.1007/s12016-019-08759-4.
10
Proteomic detection of immunoglobulin light chain variable region peptides from amyloidosis patient biopsies.从淀粉样变性患者活检组织中进行免疫球蛋白轻链可变区肽段的蛋白质组学检测。
J Proteome Res. 2015 Apr 3;14(4):1957-67. doi: 10.1021/acs.jproteome.5b00015. Epub 2015 Mar 20.

引用本文的文献

1
Uncovering New Biomarkers for Prostate Cancer Through Proteomic and Network Analysis.通过蛋白质组学和网络分析发现前列腺癌的新生物标志物。
Biology (Basel). 2025 Mar 4;14(3):256. doi: 10.3390/biology14030256.

本文引用的文献

1
Proteomics-Based Analysis and Diagnosis of Formalin-Fixed Paraffin-Embedded Amyloidosis Samples.基于蛋白质组学的福尔马林固定石蜡包埋淀粉样变性样本分析与诊断。
Methods Mol Biol. 2023;2718:213-233. doi: 10.1007/978-1-0716-3457-8_12.
2
Proteomic Analysis on Sequential Samples of Cystic Fluid Obtained from Human Brain Tumors.人脑肿瘤囊性液体连续样本的蛋白质组学分析
Cancers (Basel). 2023 Aug 11;15(16):4070. doi: 10.3390/cancers15164070.
3
Data-independent acquisition mass spectrometry reveals comprehensive plasma protein profiles in the natural history of patients with hereditary transthyretin amyloidosis (ATTRv).
数据非依赖采集质谱法揭示遗传性转甲状腺素蛋白淀粉样变性(ATTRv)患者自然史中的全面血浆蛋白谱。
Expert Rev Proteomics. 2023 Jan-Mar;20(1-3):57-69. doi: 10.1080/14789450.2023.2195096. Epub 2023 Apr 6.
4
A Streamlined High-Throughput Plasma Proteomics Platform for Clinical Proteomics with Improved Proteome Coverage, Reproducibility, and Robustness.一种简化的高通量血浆蛋白质组学平台,用于临床蛋白质组学,具有提高的蛋白质组覆盖率、重现性和稳健性。
J Am Soc Mass Spectrom. 2023 Apr 5;34(4):754-762. doi: 10.1021/jasms.3c00022. Epub 2023 Mar 28.
5
The Protein Network in Subcutaneous Fat Biopsies from Patients with AL Amyloidosis: More Than Diagnosis?AL 淀粉样变性患者皮下脂肪活检中的蛋白质网络:不仅仅是诊断?
Cells. 2023 Feb 22;12(5):699. doi: 10.3390/cells12050699.
6
Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee.淀粉样变命名 2022:更新、新型蛋白质以及国际淀粉样变性学会(ISA)命名委员会的建议。
Amyloid. 2022 Dec;29(4):213-219. doi: 10.1080/13506129.2022.2147636. Epub 2022 Nov 24.
7
Subtyping of cardiac amyloidosis by mass spectrometry-based proteomics of endomyocardial biopsies.通过心内膜心肌活检的基于质谱的蛋白质组学对心脏淀粉样变性进行亚型分类。
Amyloid. 2023 Mar;30(1):96-108. doi: 10.1080/13506129.2022.2127088. Epub 2022 Oct 9.
8
Multi-omic analyses in Abyssinian cats with primary renal amyloid deposits.伴原发性肾脏淀粉样沉积的阿比西尼亚猫的多组学分析。
Sci Rep. 2021 Apr 16;11(1):8339. doi: 10.1038/s41598-021-87168-0.
9
Clinical Amyloid Typing by Proteomics: Performance Evaluation and Data Sharing Between Two Centres.基于蛋白质组学的临床淀粉样变分型:两个中心的性能评估和数据共享。
Molecules. 2021 Mar 29;26(7):1913. doi: 10.3390/molecules26071913.
10
A Proteomic Atlas of Cardiac Amyloid Plaques.心脏淀粉样斑块的蛋白质组图谱
JACC CardioOncol. 2020 Nov;2(4):632-643. doi: 10.1016/j.jaccao.2020.08.013. Epub 2020 Nov 17.